Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EdgeRx vs Remi Meds

EdgeRx
Graded #43

Higher grade

vs+30.6
Remi Meds
Graded #539

Lower grade

The verdict

EdgeRx takes it — 79/100 to 48.4/100.

EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A men's-only compounded GLP-1 program that names its pharmacy (Strive Pharmacy, 503A since 2018) and its Chief Medical Advisor — real transparency signals most compounders skip.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEdgeRx +36
70
34
Dose & formulationEdgeRx +21
75
54
Clinical oversightEdgeRx +34
88
54
Labs & monitoringEdgeRx +28
78
50
FulfillmentEdgeRx +37
90
53
Contract termsEdgeRx +25
80
55
EdgeRx · left barRemi Meds · right bar

The numbers

MetricEdgeRxRemi Meds
WeighScore79/10048.4/100
GradeC+C
Scorecard rank#43#539
Semaglutide$229/mo$249/mo (0.25 mg dose, compounded)
Tirzepatide$299/mo$349/mo (2.25 mg dose, compounded)
Coverage46 states (excludes Arkansas, Indiana, Minnesota, South Carolina)Coverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
EdgeRx

Graded #43 · C+

Strengths

  • Named compounding pharmacy — Strive Pharmacy, a 503A facility compounding since 2018 — a genuine transparency signal most compounders lack
  • Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
  • LegitScript certified, once-weekly injectable, free shipping, no separate physician fee
  • Broad protocol menu beyond GLP-1 — MICC lipotropic, sermorelin/NAD+/glutathione, skin/hair, and sexual/hormonal health tiers

Where it loses points

  • Men's-only positioning — not an option for women
  • Dr. Starke does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
  • Third-party lab testing is claimed but no specific lab is named
  • Excludes Arkansas, Indiana, Minnesota and South Carolina (46 states)
  • Bloodwork cost is undisclosed on the Sexual & Hormonal Health tier
Remi Meds

Graded #539 · C

Strengths

  • Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
  • LegitScript verification badge on the homepage
  • Publishes 503A FDCA compliance language on the tirzepatide page
  • Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
  • Operating corporate entity disclosed (T-C Health Co)

Where it loses points

  • No named medical director, founder, or physician on any public page
  • States served not listed — 'nationwide' claim with no per-state detail
  • Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
  • Year founded and corporate history are opaque
  • Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure

Also worth a look

Another provider to compare: CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard